Founded in 2008 by a world-leading scientist, BioRegen Biomedical Co., Ltd is a Sino-foreign joint-venture which is committed to health undertakings by providing innovative and outstanding solutions for numerous patients in many important medical fields.

Based on its self-crosslinking technology, which is protected by 44 international patents, BioRegen developed unique and novel products - crosslinked hyaluronic acid gel for postoperative adhesion prevention, injury healing and tissue regeneration.